Moreover, Bove et al. [31] noted that serum IGFBP1 levels are decreased during the post-menopausal phase in MS females leading to worsening patient symptoms compared to MS male individuals at the same age. The gene discussed is IGFBP1; the disease is myeloid sarcoma.